WuXi PharmaTech (Cayman) Stock Price, News & Analysis (NYSE:WX)

$45.91 0.00 (0.00 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$45.91
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market Capitalization$3.27 billion
P/E Ratio38.91
Dividend YieldN/A

About WuXi PharmaTech (Cayman) (NYSE:WX)

WuXi PharmaTech (Cayman) logoWuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.

Receive WX News and Ratings via Email

Sign-up to receive the latest news and ratings for WX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio38.9067796610169
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS$1.18
Net IncomeN/A
Net Margins7.52%
Return on Equity6.93%
Return on Assets4.67%


Outstanding SharesN/A

WuXi PharmaTech (Cayman) (NYSE:WX) Frequently Asked Questions

What is WuXi PharmaTech (Cayman)'s stock symbol?

WuXi PharmaTech (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "WX."

How were WuXi PharmaTech (Cayman)'s earnings last quarter?

WuXi PharmaTech (Cayman) Inc. (NYSE:WX) released its quarterly earnings results on Tuesday, November, 3rd. The medical research company reported $0.31 EPS for the quarter, meeting analysts' consensus estimates of $0.31. The medical research company earned $213.60 million during the quarter, compared to analysts' expectations of $205.24 million. WuXi PharmaTech (Cayman) had a return on equity of 6.93% and a net margin of 7.52%. The firm's revenue was up 23.0% compared to the same quarter last year. During the same period last year, the business posted $0.54 earnings per share. View WuXi PharmaTech (Cayman)'s Earnings History.

Who are some of WuXi PharmaTech (Cayman)'s key competitors?

How do I buy WuXi PharmaTech (Cayman) stock?

Shares of WuXi PharmaTech (Cayman) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is WuXi PharmaTech (Cayman)'s stock price today?

One share of WuXi PharmaTech (Cayman) stock can currently be purchased for approximately $45.91.

How big of a company is WuXi PharmaTech (Cayman)?

WuXi PharmaTech (Cayman) has a market capitalization of $3.27 billion.

How can I contact WuXi PharmaTech (Cayman)?

WuXi PharmaTech (Cayman)'s mailing address is 288 Fute Zhong Road China (Shanghai) Pilot Free Trade Zone, SHANGHAI, SHA 200131, China. The medical research company can be reached via phone at +86-21-50461111.

MarketBeat Community Rating for WuXi PharmaTech (Cayman) (WX)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  140 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  237
MarketBeat's community ratings are surveys of what our community members think about WuXi PharmaTech (Cayman) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

WuXi PharmaTech (Cayman) (NYSE:WX) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


WuXi PharmaTech (Cayman) (NYSE:WX) Earnings History and Estimates Chart

Earnings by Quarter for WuXi PharmaTech (Cayman) (NYSE:WX)

WuXi PharmaTech (Cayman) (NYSE WX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2015Q3$0.31$0.31$205.24 million$213.60 millionViewN/AView Earnings Details
8/13/2015Q215$0.39$0.38$195.26 million$194.14 millionViewListenView Earnings Details
5/13/2015Q1$0.32$0.36$174.29 million$180.00 millionViewListenView Earnings Details
3/5/2015Q414$0.53$0.55$189.54 million$190.60 millionViewListenView Earnings Details
11/12/2014Q314$0.48$0.54$172.60 million$173.60 millionViewListenView Earnings Details
8/13/2014Q214$0.47$0.49$162.11 million$163.40 millionViewListenView Earnings Details
5/14/2014Q114$0.39$0.30$145.00 million$146.70 millionViewListenView Earnings Details
3/5/2014Q413$0.43$0.53$155.76 million$157.10 millionViewN/AView Earnings Details
11/13/2013Q313$0.39$0.47$145.29 million$146.70 millionViewListenView Earnings Details
8/12/2013Q2 2013$0.39$0.46$141.10 million$142.33 millionViewN/AView Earnings Details
5/13/2013Q1 2013$0.32$0.35$130.02 million$131.90 millionViewListenView Earnings Details
3/7/2013Q4 2012$0.30$0.38$123.71 million$125.70 millionViewListenView Earnings Details
11/12/2012Q312$0.30$0.36$123.17 million$125.84 millionViewN/AView Earnings Details
8/13/2012$0.30$0.33ViewN/AView Earnings Details
5/10/2012$0.26$0.33ViewN/AView Earnings Details
3/8/2012$0.26$0.31ViewN/AView Earnings Details
11/10/2011$0.27$0.31ViewN/AView Earnings Details
8/10/2011Q2 2011$0.25$0.25ViewN/AView Earnings Details
5/10/2011Q1 2011$0.22$0.25ViewN/AView Earnings Details
3/8/2011Q4 2010$0.21$0.24ViewN/AView Earnings Details
11/9/2010Q3 2010$0.43$0.27ViewN/AView Earnings Details
8/2/2010Q2 2010$0.20$0.18ViewN/AView Earnings Details
5/11/2010Q1 2010$0.19$0.22ViewN/AView Earnings Details
3/8/2010Q4 2009$0.16$0.17ViewN/AView Earnings Details
11/16/2009Q3 2009$0.15$0.20ViewN/AView Earnings Details
8/11/2009Q2 2009$0.12$0.20ViewN/AView Earnings Details
5/14/2009Q1 2009$0.08$0.16ViewN/AView Earnings Details
3/25/2009Q4 2008$0.06$0.10ViewN/AView Earnings Details
11/12/2008Q3 2008$0.10$0.18ViewN/AView Earnings Details
8/13/2008Q2 2008$0.18$0.17ViewN/AView Earnings Details
5/27/2008Q1 2008$0.14$0.19ViewN/AView Earnings Details
3/12/2008Q4 2007$0.12$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


WuXi PharmaTech (Cayman) (NYSE:WX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for WuXi PharmaTech (Cayman) (NYSE:WX)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for WuXi PharmaTech (Cayman) (NYSE WX)

No insider trades for this company have been tracked by MarketBeat.com


WuXi PharmaTech (Cayman) (NYSE WX) News Headlines

Head-To-Head Comparison: WuXi PharmaTech (Cayman) (WX) and Intrexon (XON)Head-To-Head Comparison: WuXi PharmaTech (Cayman) (WX) and Intrexon (XON)
www.americanbankingnews.com - February 8 at 7:02 PM
Financial Review: WuXi PharmaTech (Cayman) (WX) and Its RivalsFinancial Review: WuXi PharmaTech (Cayman) (WX) and Its Rivals
www.americanbankingnews.com - January 24 at 7:06 PM
Head to Head Contrast: WuXi PharmaTech (Cayman) (WX) vs. The CompetitionHead to Head Contrast: WuXi PharmaTech (Cayman) (WX) vs. The Competition
www.americanbankingnews.com - January 14 at 9:36 PM
Reviewing WuXi PharmaTech (Cayman) (WX) and Its CompetitorsReviewing WuXi PharmaTech (Cayman) (WX) and Its Competitors
www.americanbankingnews.com - January 3 at 11:30 PM
WuXi PharmaTech (Cayman) (WX) vs. The Competition Head to Head SurveyWuXi PharmaTech (Cayman) (WX) vs. The Competition Head to Head Survey
www.americanbankingnews.com - January 1 at 7:28 AM
When Exile Beats Chinas BackdoorWhen Exile Beats China's Backdoor
www.bloomberg.com - November 13 at 10:41 AM
Analyzing WuXi PharmaTech (Cayman) (WX) & PAREXEL International (PRXL)Analyzing WuXi PharmaTech (Cayman) (WX) & PAREXEL International (PRXL)
www.americanbankingnews.com - November 10 at 3:10 AM
WuXi PharmaTech (Cayman) (WX) and Organovo Holdings (ONVO) Head-To-Head AnalysisWuXi PharmaTech (Cayman) (WX) and Organovo Holdings (ONVO) Head-To-Head Analysis
www.americanbankingnews.com - November 8 at 9:32 PM
UPDATE 2-WuXi Biologics prices HK IPO at top as investors seek growth businessUPDATE 2-WuXi Biologics prices HK IPO at top as investors seek growth business
www.reuters.com - June 6 at 2:46 AM
Sky People Fruit Juice (An Update)Sky People Fruit Juice (An Update)
seekingalpha.com - January 9 at 3:22 PM
Form N-PX Managed Portfolio Series For: Jun 30Form N-PX Managed Portfolio Series For: Jun 30
www.streetinsider.com - August 22 at 8:17 PM
Chinas Banks Help Finance $157 Billion M&A SpreeChina's Banks Help Finance $157 Billion M&A Spree
www.bloomberg.com - August 9 at 8:40 PM
Viral Clearance Market Worth 510.3 Million USD by 2020Viral Clearance Market Worth 510.3 Million USD by 2020
www.marketwatch.com - April 4 at 10:45 AM

SEC Filings

WuXi PharmaTech (Cayman) (NYSE:WX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


WuXi PharmaTech (Cayman) (NYSE:WX) Income Statement, Balance Sheet and Cash Flow Statement


WuXi PharmaTech (Cayman) (NYSE WX) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.